1. One molecule, a broad range of industrial applications
Within the landscape of applied biotechnology, Hyaluronic Acid represents one of the most versatile and high-performing vectors for formulation development.
Its clinical and industrial relevance lies in the perfect balance between its hydrophilic properties and its adjustable rheological profile: its remarkable water-retention capacity, combined with tunable viscoelasticity, makes it a key ingredient in high-value fields such as regenerative orthopaedics, ophthalmic viscosurgery, advanced dermatology and aesthetic medicine.
(In liquid formulations or medical devices, its sodium salt form, Sodium Hyaluronate, is commonly used and is preferred for its optimal solubility and stability at physiological pH).
For an innovation-driven company, the challenge does not lie in the mere availability of the molecule, but rather in the rigorous selection of the most suitable chemical-physical specification for the mechanism of action of the final product.
In this context, MIAT acts as a strategic bridge between primary production and formulation requirements, offering a diversified portfolio capable of covering the full spectrum of demand.
2. From pre-filled syringes to topical products: tailored solutions for every formulation
The versatility of the Hyaluronic Acid distributed by MIAT is reflected in the availability of different viscosity grades and molecular weights, all obtained through a single, rigorous biofermentation process.
Each intended use requires targeted parameters in terms of molecular weight, from low-kilodalton fractions up to very high molecular masses, and intrinsic viscosity, both essential for determining enzymatic degradation times and the mechanical response in target tissues:
- Injectable devices in pre-filled syringes (PFS): high-viscosity, high-molecular-weight formulations intended for intra-articular and tendon viscosupplementation in osteoarthritis, as well as matrices suitable for cross-linking in aesthetic medicine and tissue volume restoration.
- Ophthalmic Viscosurgical Devices (OVDs): extremely high-purity grades formulated to protect delicate structures such as the corneal endothelium and retina during complex surgical procedures, including cataract extraction or glaucoma surgery.
- Medical devices for topical and mucosal use: medium-low molecular weights designed to provide hydrating, reparative and re-epithelialising action in ophthalmic products for dry eye syndrome, as well as in dermatological and gynaecological formulations for tissue regeneration.
Providing rigorously controlled particle size and viscosity ranges enables Research and Development departments to optimise batch processability and accurately estimate the release kinetics or in vivo residence time of the active ingredient.
3. Supply chain experience and regulatory compliance: the MIAT approach
In B2B supply for the production of pharmaceuticals and medical devices, the concept of quality goes beyond the analytical specification of the product alone and is fully integrated with the relevant regulatory framework.
Thanks to a well-established historical presence in the sector and long-standing strategic relationships with leading global active ingredient manufacturers, MIAT ensures transparent supply chain management.
The placing on the market of Hyaluronic Acid is supported by a documentary dossier suitable for meeting the most stringent supplier qualification processes and audit requirements:
- GMP API compliance: certification that the biosynthesis and purification process is carried out in full compliance with Good Manufacturing Practices for pharmaceutical active ingredients.
- Traceability and ISO standards: comprehensive traceability of each production batch, ensuring consistent chemical-physical reproducibility over time and reducing variability between supplies.
Continuity of supply and timely delivery of supporting documentation allow Regulatory and Quality Assurance teams at customer companies to manage authorisation procedures smoothly, mitigating operational risks associated with raw material sourcing.
For further information, read also https://www.miat.it/2025/03/05/il-sistema-qualita-miat/
4. A solid reference point for future projects
Addressing the challenges of a regulated market requires much more than a simple commercial transaction: it requires reliability, cross-functional technical expertise and an in-depth understanding of formulation processes.
MIAT’s approach is based on the convergence of the breadth of its available range, rigorous quality controls and a well-established understanding of supply chain dynamics.
By positioning itself as a leading partner for the pharmaceutical and medical device industries, MIAT supports companies in selecting the most suitable molecular specifications, turning compliance requirements into tangible value for the success of industrial projects.
Do you need to define the technical specifications for your next project? MIAT’s technical team is available to assess the viscosity, molecular weight and compliance documentation requirements for your application.
